Role of Prophylactic Tranexamic Acid in Reducing Blood Loss during Elective Caesarean Section: A Randomized Controlled Study
Introduction: Obstetric haemorrhage accounts for 20-25% of maternal mortality and morbidity. Anti-fibrinolytics are being widely used in field of surgery. It is also used to reduce heavy menstrual blood loss. Aim: To analyse the effectiveness of Tranexamic Acid (TXA) in reducing blood loss duri...
Main Authors: | SJ Dhivya Lakshmi, Reena Abraham |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2016-12-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/9050/21702_CE[Ra1]_F(DK)_PF1(PI_RK)_PFA(AK)_PF2(PAG).pdf |
Similar Items
-
Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial
by: Anne-Sophie Bouthors, et al.
Published: (2018-03-01) -
Effectiveness of Tranexamic Acid for Reducing Postpartum Blood Loss in the First Two Hours after Vaginal Delivery: A Randomised Controlled Trial
by: Anuchat Sujita, et al.
Published: (2018-03-01) -
Management of bleeding from morbidly adherent placenta during elective repeat caesarean section: retrospective -record -based study
by: Saad El Gelany, et al.
Published: (2019-03-01) -
Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage
by: Ian Roberts, et al.
Published: (2018-05-01) -
Effect of Intravenous Tranexamic Acid Administration on Blood Loss during and after Caesarean Delivery: A Randomised Controlled Study
by: Shyamali Dutta, et al.
Published: (2020-10-01)